Metrics to compare | 1BSL01AE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1BSL01AEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.2x | 16.2x | −0.4x | |
PEG Ratio | −0.22 | 0.16 | 0.00 | |
Price/Book | 0.6x | 1.2x | 2.6x | |
Price / LTM Sales | 0.7x | 2.0x | 3.1x | |
Upside (Analyst Target) | - | 5.7% | 51.8% | |
Fair Value Upside | Unlock | 8.3% | 7.5% | Unlock |
Biotika a.s., a biotechnology company, manufactures active pharmaceutical ingredients in Slovakia and internationally. It is involved in manufacturing Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate; contract manufacturing of Gramicidin S Hydrocholoride; import and distribution of active ingredients; production of chemical products, such as disinfectants and organic chemicals; and production of human and veterinary medicines, food products, including beverages, protein substances, and derivatives. The company also engages in research and development in the field of natural and technical sciences; production of feed additives and export to third countries; production and sale of compost and organic fertilizer; and rental of real estate and movable property. Biotika a.s. was founded in 1953 and is based in Slovenská Lupca, Slovakia.